Sukhatme Mayukh sold ROIV
August 18, 2026 · Form 4 insider transaction
Sukhatme Mayukh sold 105,141 shares of Roivant Sciences Ltd. at $36.59 per share, a transaction worth $3.85M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
105,141
Price
$36.59
Total value
$3.85M
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2026
Filing dateAugust 18, 2026
Shares owned after18,630,739
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.